PROGNOSIS OF HEART FAILURE FOLLOWING CARDIOTOXIC BREAST CANCER CHEMOTHERAPY: A RETROSPECTIVE MATCHED COHORT STUDY
2020
Cardiotoxic chemotherapy for early-stage breast cancer (EBC) increases the risk of heart failure (HF) but there are limited data on its prognosis relative to HF from other etiologies.
Using administrative databases, we conducted a retrospective population-based matched cohort study of women newly
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI